Video Experimental Relacionado
Updated: Jul 28, 2026
06:04
Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
Zomepirac sodio. también conocido como Zomepirac sodio. Un nuevo analgésico no adictivo
JAMA
|July 24, 1981
Resumen
Zomepirac sodio ofrece un alivio eficaz del dolor comparable a los narcóticos, sin causar dependencia. Este analgésico no opioide también proporciona beneficios antiinflamatorios y antipiréticos con efectos secundarios manejables.
Área de la Ciencia:
- Farmacología Farmacología.
- Manejo del dolor Manejo del dolor.
- Desarrollo de Drogas Desarrollo de Drogas.
Sus antecedentes:
- Los analgésicos no opioides son cruciales para el manejo del dolor.
- Los analgésicos existentes como la aspirina y la codeína tienen limitaciones.
- La necesidad de opciones efectivas y seguras de alivio del dolor persiste.
Objetivo del estudio:
- Evaluar la eficacia y seguridad del zomepiraco sódico como analgésico oral.
- Para comparar la eficacia del sodio zomepirac con otros analgésicos comunes.
- Para evaluar el potencial de tolerancia o dependencia con el zomepirac sódico.
Principales métodos:
- Ensayos clínicos que involucran a pacientes con dolor leve a severo.
- La administración oral de zomepiraco sódico.
- Análisis comparativo de los efectos analgésicos, antiinflamatorios y antipiréticos.
- Evaluación de los efectos secundarios y el potencial de tolerancia o dependencia.
Principales resultados:
- Zomepirac sodio demostró una analgesia oral significativa para el dolor leve a severo.
- Su eficacia fue superior a la de la aspirina o la codeína sola y comparable a las combinaciones de codeína.
- La analgesia fue comparable a la morfina intramuscular en el dolor postoperatorio.
- No se observó tolerancia, dependencia psíquica o física con el uso a largo plazo.
- Zomepirac sodio exhibió propiedades antiinflamatorias y antipiréticas, inhibiendo la síntesis de prostaglandinas.
- Las reacciones gastrointestinales fueron los efectos secundarios más comunes, generalmente bien tolerados.
Conclusiones:
- Zomepirac sodio es un potente analgésico no opioide eficaz por vía oral.
- Ofrece una alternativa favorable a los analgésicos existentes, incluidos los narcóticos, para varios tipos de dolor.
- El medicamento presenta un bajo riesgo de tolerancia o dependencia, incluso con el uso prolongado.
- Sus acciones antiinflamatorias y antipiréticas, junto con un perfil de seguridad generalmente bueno, lo convierten en una valiosa opción terapéutica.
Videos de Conceptos Relacionados
01:44Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...